Home
/

SIADH

REVIEWED BY
Bill Maish, MD
Clinical Content Consultant
Published
May 30, 2026
Last updated
May 30, 2026
Key takeaway:

Blood testing for SIADH measures serum Sodium and Albumin—Sodium to reveal dilutional hyponatremia from excess ADH retaining water, and Albumin to distinguish this water-overload pattern from edematous states. In SIADH, Sodium drifts below the normal 135–145 mEq/L range while Albumin remains characteristically normal (3.5–5.0 g/dL), driving symptoms from headache and nausea to confusion or seizures as plasma hypotonicity is associated with brain-cell swelling.

Read more →
Table of contents

SIADH and the Water-Balance Story in Sodium

SIADH biomarkers are blood signals that show how strongly the body’s water‑saving system is acting and how that action dilutes the bloodstream. The central signal is antidiuretic hormone (ADH, arginine vasopressin), released from the posterior pituitary; in SIADH this signal is inappropriately “on,” telling the kidneys to hold water. Because ADH itself is short‑lived, its stable companion, copeptin, often serves as a practical fingerprint of vasopressin activity. The downstream imprint of this hormone appears in core chemistry markers: the concentration of sodium (a proxy for water balance), the overall concentration of the blood (serum osmolality), and the level of dissolved waste solutes such as urea and uric acid that reflect dilution and solute handling. Together, these biomarkers capture both cause and effect—hormonal drive and its impact on blood concentration—making the ADH‑driven water retention of SIADH visible and trackable. In short, SIADH biomarker testing translates the body’s water‑control story into measurable signals that guide focused, safe care.

Reading Sodium and Albumin for Water Balance

SIADH is a water-balance disorder driven by excess antidiuretic hormone, so the key blood signals are those that reflect body water and oncotic pressure. Serum sodium shows how diluted the blood is (and how water shifts into cells, especially in the brain), while albumin reflects protein-based oncotic pressure and helps distinguish true volume overload states from the dilutional picture typical of SIADH. Together, they map the brain–kidney–endocrine axis that keeps our fluids in balance.Sodium typically sits around 135–145, with best function near the middle. Albumin usually ranges about 3.5–5, with healthier reserves in the mid-to-high range. In SIADH, sodium drifts below normal while albumin is usually normal; a clearly high sodium level points away from SIADH toward water loss states.When sodium falls, plasma becomes hypotonic and water moves into brain cells. People may feel headache, nausea, fogginess, unsteadiness, or muscle cramps; deeper drops can trigger confusion, seizures, or coma. Older adults often show gait instability and falls even with mild reductions. Children can develop cerebral edema rapidly, and premenopausal women are at higher risk of hyponatremic brain swelling; pregnancy naturally lowers the sodium setpoint slightly, so symptoms can escalate faster when SIADH occurs. If albumin is low, that suggests alternative causes like cirrhosis, nephrotic syndrome, or heart failure (edema and third spacing), rather than SIADH. Conversely, high albumin or high sodium signals hemoconcentration/dehydration and the opposite physiology.Big picture: blood testing anchors the diagnosis of SIADH by linking ADH action to kidney water handling and brain vulnerability, and it helps separate look-alike hyponatremias. It also cues clinicians to upstream drivers—lung and CNS disease, medications—and flags risks of chronic hyponatremia, including cognitive effects, falls, and bone loss.

The Honest Reach of a Sodium Panel for SIADH

SIADH (Syndrome of Inappropriate Antidiuretic Hormone Secretion) blood testing is important because it reveals how well your body manages water balance, which directly affects brain function, energy levels, cardiovascular stability, and overall metabolic health. At Superpower, we focus on two key biomarkers for SIADH: sodium and albumin. These markers help us understand how your body is handling fluids and maintaining the right concentration of salts in your blood.Sodium is a major electrolyte that helps regulate fluid balance, nerve signaling, and muscle function. In SIADH, excess antidiuretic hormone causes the body to retain water, diluting sodium levels in the blood—a condition called hyponatremia. Albumin is a protein made by the liver that helps keep fluid within blood vessels and transports hormones, vitamins, and drugs. While albumin is not directly altered by SIADH, it provides context for interpreting sodium results, as low albumin can also affect fluid distribution and blood volume.Healthy sodium levels are essential for stable nerve and muscle activity, mental clarity, and cardiovascular function. When sodium drops due to SIADH, it can lead to confusion, weakness, and even serious neurological symptoms. Albumin supports vascular stability and helps ensure that fluid shifts caused by SIADH do not lead to swelling or low blood pressure.Interpretation of SIADH blood tests can be influenced by factors such as age, pregnancy, acute or chronic illness, certain medications (like diuretics or antidepressants), and laboratory assay differences. These factors should be considered when evaluating sodium and albumin results.

FAQs

It checks how your body controls water and salt under antidiuretic hormone (ADH). The key signal is low blood sodium from excess water retention (dilutional hyponatremia). Superpower tests your blood for Sodium and Albumin. Sodium reflects the water–salt balance; Albumin helps assess oncotic pressure and volume status. Blood testing screens for SIADH and guides next steps, but confirmation typically also needs serum/urine osmolality, urine sodium, and exclusion of thyroid/adrenal problems.

It detects dilutional hyponatremia early, a state that can affect brain function if severe. Sodium shows the degree and trend of water excess; Albumin helps distinguish euvolemic hyponatremia (often SIADH) from states with low oncotic pressure or fluid overload. Together, they frame whether water regulation, not salt loss, is the main problem, and whether additional urine and endocrine tests are warranted.

Yes. With Superpower, our team member can organize a blood draw in your home. We’ll collect Sodium and Albumin and handle logistics so results flow directly into your dashboard.

Start with a baseline when SIADH is suspected, then recheck to confirm the trend. If sodium is changing, repeat testing is typically frequent until stable. Once stable, periodic monitoring helps ensure sodium remains in a safe range and alerts you to relapse. The cadence depends on how fast your sodium is moving and any changes in medications or health status.

Sodium shifts with water balance and ADH activity. Pain, nausea, surgery, lung or brain disease, infections, and drugs like SSRIs, carbamazepine, and thiazides can raise ADH effect and lower sodium. Low solute intake can worsen dilution. Albumin falls with liver disease, inflammation, malnutrition, kidney protein loss, or fluid overload, and may look relatively lower with hemodilution. Normal albumin favors euvolemia; low albumin points to other volume states.

No special fasting is required. Keep your usual diet and routine. Avoid overdrinking water right before the draw, as acute water loading can transiently lower sodium. Tell us about recent illnesses and medications that influence water balance. Superpower will collect Sodium and Albumin under standard phlebotomy conditions.

References

  1. Warren, A. M., Grossmann, M., Christ-Crain, M., & Russell, N. (2023). Syndrome of inappropriate antidiuresis: From pathophysiology to management. Endocrine Reviews, 44(5), 819-861. https://doi.org/10.1210/endrev/bnad010
  2. Spasovski, G., Vanholder, R., Allolio, B., Annane, D., Ball, S., Bichet, D., ... Nagler, E. (2014). Clinical practice guideline on diagnosis and treatment of hyponatraemia. European Journal of Endocrinology, 170(3), G1-G47. https://doi.org/10.1530/EJE-13-1020
  3. Christ-Crain, M., Morgenthaler, N. G., & Fenske, W. (2016). Copeptin as a biomarker and a diagnostic tool in the evaluation of patients with polyuria-polydipsia and hyponatremia. Best Practice & Research Clinical Endocrinology & Metabolism, 30(2), 235-247. https://doi.org/10.1016/j.beem.2016.02.003
  4. Bhasin-Chhabra, B., Veitla, V., Weinberg, S., & Koratala, A. (2022). Demystifying hyponatremia: A clinical guide to evaluation and management. Nutrition in Clinical Practice, 37(5), 1023-1032. https://doi.org/10.1002/ncp.10907
  5. Imbriano, L. J., Mattana, J., Drakakis, J., & Maesaka, J. K. (2016). Identifying different causes of hyponatremia with fractional excretion of uric acid. The American Journal of the Medical Sciences, 352(4), 385-390. https://doi.org/10.1016/j.amjms.2016.05.035

Built by the world’s top doctors and scientists

Dr Anant Vinjamoori, MD

Chief Longevity Officer, Superpower

Board-certified longevity physician. Previously product leader at Virta Health & CMO at Modern Age. Featured in  WSJ, Forbes, and Fortune.

Learn more

Dr Leigh Erin Connealy, MD

Clinician & Founder of The Centre for New Medicine

Leads the largest integrative medical clinic in North America. A pioneer in integrative oncology.

Learn more

Dr Robert Lufkin

UCLA Medical Professor, NYT Bestselling Author

A leading voice on metabolic health and longevity as shown in The Today Show, USA Today and FOX.

Learn more

Dr Abe Malkin

Founder & Medical Director of Concierge MD

Leads a nationwide medical practice, and Drip Hydration, a mobile IV therapeutics company

Learn more
Membership slide 1
Membership slide 1
Membership slide 2
Membership slide 3
1 / 3

Your membership starts here

Annual 100+ biomarker panel

Data dashboard and digital twin

Upload past labs and connect wearables

Personalized health protocol

24/7 care team access

AI companion for all health questions

Marketplace with additional solutions

$199

/year*

Billed annually

HSA/ FSA eligible
Cancel anytime
Results in a week

* Pricing may vary for members in New York and New Jersey